Publication Details
Publication: Nihon Ryutsu Sangyo Shimbun (日本流通産業新聞), Evidence-Based Ingredients Special Feature
Publication Date: March 26, 2026
Original Language: Japanese
English Translation of the Published Article
Note: The following English text is a faithful rendering of the information presented in the original Japanese media article. The content reflects the original media coverage.
Nihon Ryutsu Sangyo Shimbun featured Toei Shinyaku and outdoor-cultivated Agaricus KA21 in a special issue focusing on evidence-based ingredients. The article presents KA21 as an ingredient backed by long-term research and describes the company’s strategy of building scientific evidence through publications, patents, collaborative studies and academic presentations.
The article explains that Toei Shinyaku has researched Agaricus KA21 for more than 30 years and has accumulated a substantial body of scientific work. It refers to research in areas including men’s health, stress-related cognitive function, ovarian function, skin and beauty.
The feature also describes human research in middle-aged and older men and notes intellectual-property developments associated with the company’s research. These activities are presented as part of a broader effort to establish KA21 as a scientifically supported ingredient.
The article further introduces Toei Shinyaku’s commercial development of KA21, including products for professional channels and proposals for OEM applications, linking the company’s research program with practical product development.
日本語記事概要 / Japanese Summary
日本流通産業新聞2026年3月26日号「エビデンスのある素材」特集で、東栄新薬の露地栽培アガリクスKA21が紹介されました。30年以上にわたる研究、国際論文、特許、大学等との共同研究、学会発表をはじめ、メンズヘルス、ストレス・認知機能、卵巣機能、美容など複数の研究領域が取り上げられています。研究成果を医療・専門チャネル向け製品やOEM提案などの商品開発につなげる取り組みについても紹介されています。